M&A Deal Count Expected to Rebound Following Tepid Q1

The Pros and Cons of Selling Your Business to Independent Sponsors

What the FTC’s Non-Compete Ruling Means for Physicians and Private Equity

Takeaways from the 2023 Virginia Capital Conference

Consolidated Appropriations Act of 2023 Provides Security for M&A Brokers

Staff Spotlight: Overton Ragland

Contact Us